News | May 17, 2023
Pfizer Ltd posts Q4 FY23 PAT at Rs. 129.65 Cr
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
The company has reported total income of Rs. 604.02 crores during the period ended March 31, 2023
The company has reported total income of Rs. 149.78 crores during the period ended March 31, 2023
Dr. Lal Path Labs has reported total income of Rs. 505.2 crores during the period ended March 31, 2023
The company has reported total income of Rs. 4467.35 crores during the quarter ended March 31, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 125.35 crores during the period ended March 31, 2023
The company has reported total income of Rs. 1407.34 crores during the period ended March 31, 2023
The company has reported total income of Rs. 918.67 crores during the period ended March 31, 2023
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
The company has posted net profit of Rs.464.4 crores for the Financial Year ended March 31, 2023
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
Subscribe To Our Newsletter & Stay Updated
